AR and Familial prostate cancer: Collectively, these AR-dependent mechanisms enable prostate cancer cells to resist androgen deprivation and continue to proliferate, highlighting the complexity of CRPC biology and the need for advanced therapeutic strategies that can effectively overcome or bypass AR signaling pathways.